Many innovations have been implemented in the cardiovascular care sector, but there are still further gains to be made.
breeding ground for stem cell therapy.
Regenerative medicine wants to make the transition to large-scale clinical application with stem cell therapy and tissue engineering. This requires reliable production of the required materials. We develop efficient systems for this purpose. We combine our mechatronics and systems engineering expertise with our experience in medical devices, biotechnology and Good Manufacturing Practice.
“we combine multidisciplinary engineering with biotechnology.”
We provide process development for academic and industrial partners. We do this with multidisciplinary teams. For example, we are able to scale up the production of specific stem cells or tissues. We apply the highest quality standards and documentation, qualification and verification guidelines for this purpose. This is part of our DNA.
Michiel Jannink
more market segments.
cardiovascular
diagnostic imaging
For many disorders, high-quality images are essential for diagnostics and therapy. The...
home treatment & wearables
People will be managing their own health, with increased...
interventional systems
Medical interventions are increasingly minimally invasive. This reduces the chance of...
in-vitro diagnostics
The demand for in vitro diagnostics (IVD) for fast, targeted healthcare is growing. We...
radiation oncology
Radiation therapy is the most often used option for treating cancer. We...
critical care systems
The care for a patient in critical condition is of vital importance...